theory clinical_23_4
imports Main

begin

typedecl entity
typedecl event

consts
  CTNNB1Mutation :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"
  BetaCatenin :: "entity ⇒ bool"
  Proliferation :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  YAPInhibitor :: "entity ⇒ bool"
  BetaCateninActivity :: "entity ⇒ bool"
  EffectiveInInhibiting :: "entity ⇒ entity ⇒ bool"
  Cause :: "event ⇒ entity ⇒ bool"
  Reduce :: "event ⇒ bool"
  CellProliferation :: "event ⇒ bool"
  Inhibiting :: "event ⇒ bool"
  Leads :: "event ⇒ bool"
  EffectiveTreatment :: "event ⇒ bool"
  Treatment :: "event ⇒ bool"
  Reduces :: "event ⇒ bool"
  EffectiveInTreating :: "entity ⇒ entity ⇒ bool"

(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
axiomatization where
  explanation_1: "∀x y z e. CTNNB1Mutation x ∧ Cell y ∧ BetaCatenin z ∧ Proliferation e ∧ Agent e x ∧ Patient e y ∧ Via e z"

(* Explanation 2: A YAP inhibitor may be effective in inhibiting β-catenin activity. *)
axiomatization where
  explanation_2: "∃x y. YAPInhibitor x ∧ BetaCateninActivity y ⟶ EffectiveInInhibiting x y"

(* Explanation 3: Inhibiting β-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNB1. *)
axiomatization where
  explanation_3: "∀x y z e1 e2. BetaCateninActivity x ∧ Cell y ∧ CTNNB1Mutation z ∧ Proliferation e1 ∧ Cause e1 z ⟶ (Reduce e2 ∧ Agent e2 x ∧ Patient e2 y)"

(* Explanation 4: Inhibiting β-catenin activity through a YAP inhibitor directly leads to effective treatment of patients with activating CTNNB1 mutations by reducing cell proliferation. *)
axiomatization where
  explanation_4: "∃x y z e1 e2 e3. YAPInhibitor x ∧ BetaCateninActivity y ∧ CTNNB1Mutation z ∧ CellProliferation e1 ∧ Inhibiting e2 ∧ Agent e2 y ∧ Patient e2 z ∧ Leads e3 ∧ Agent e3 x ∧ Patient e3 z ∧ EffectiveTreatment e3"

(* Explanation 5: A YAP inhibitor, by inhibiting β-catenin activity, effectively reduces cell proliferation, leading to the treatment of patients with activating CTNNB1 mutations. *)
axiomatization where
  explanation_5: "∃x y z e1 e2 e3. YAPInhibitor x ∧ BetaCateninActivity y ∧ CellProliferation e1 ∧ Inhibiting e1 ∧ Agent e1 y ∧ Patient e1 z ∧ Reduces e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Leads e3 ∧ Agent e3 x ∧ Patient e3 z ∧ Treatment e3"

theorem hypothesis:
  assumes asm: "YAPInhibitor x ∧ CTNNB1Mutation y"
  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)
  shows "∃x y. YAPInhibitor x ∧ CTNNB1Mutation y ⟶ EffectiveInTreating x y"
proof -
  (* From the premise, we have known information about the YAP inhibitor and CTNNB1 mutation. *)
  from asm have "YAPInhibitor x ∧ CTNNB1Mutation y" by simp
  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, treatment of patients with activating CTNNB1 mutations) *)
  (* D is from explanatory sentence 2, E is from explanatory sentence 4 and 5. *)
  (* We already have YAPInhibitor x, so we can infer treatment of patients with activating CTNNB1 mutations. *)
  then have "EffectiveInTreating x y" sledgehammer
  then show ?thesis <ATP>
qed

end
